Enanta Pharmaceuticals, Inc. (ENTA) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
ENTA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ENTA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 93.0% | -130.7% | -125.4% |
| 2024 | 100.0% | -179.9% | -171.6% |
| 2023 | 100.0% | -173.2% | -169.0% |
| 2022 | 100.0% | -143.7% | -141.3% |
| 2021 | 100.0% | -112.9% | -81.4% |
Download Data
Export ENTA earnings history in CSV or JSON format
Free sign-in required to download data
Enanta Pharmaceuticals, Inc. (ENTA) Earnings Overview
As of May 6, 2026, Enanta Pharmaceuticals, Inc. (ENTA) reported trailing twelve-month net income of -$72M, reflecting +29.9% year-over-year growth. The company earned $-2.49 per diluted share over the past four quarters, with a net profit margin of -125.4%.
Looking at the long-term picture, ENTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $79M in fiscal 2015.
Enanta Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACHV (-$52M net income), AGIO (-$423M net income, -764.0% margin), ARQT (-$16M net income, -4.3% margin), ENTA has comparable earnings metrics. Compare ENTA vs ACHV →
ENTA Earnings vs Peers
Earnings metrics vs comparable public companies
ENTA Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$82M | +29.4% | -$85M | $-3.84 | -125.4% | -130.7% |
| 2024 | -$116M | +13.3% | -$122M | $-5.48 | -171.6% | -179.9% |
| 2023 | -$134M | -9.9% | -$137M | $-6.38 | -169.0% | -173.2% |
| 2022 | -$122M | -54.1% | -$124M | $-5.91 | -141.3% | -143.7% |
| 2021 | -$79M | -118.4% | -$110M | $-3.92 | -81.4% | -112.9% |
| 2020 | -$36M | -178.0% | -$42M | $-1.81 | -29.5% | -34.0% |
| 2019 | $46M | -35.5% | $37M | $2.21 | 22.6% | 17.9% |
| 2018 | $72M | +306.3% | $88M | $3.48 | 34.8% | 42.7% |
| 2017 | $18M | -18.3% | $25M | $0.91 | 17.2% | 23.9% |
| 2016 | $22M | -72.6% | $31M | $1.13 | 24.5% | 34.9% |
See ENTA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ENTA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ENTA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonENTA — Frequently Asked Questions
Quick answers to the most common questions about buying ENTA stock.
Is ENTA growing earnings?
ENTA EPS is $-2.49, with earnings growth accelerating to +29.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-72M.
What are ENTA's profit margins?
Enanta Pharmaceuticals, Inc. net margin is -125.4%, with operating margin at -130.7%. Below-average margins reflect competitive or cost pressures.
How consistent are ENTA's earnings?
ENTA earnings data spans 2011-2025. The accelerating earnings trend is +29.9% YoY. Historical data enables comparison across business cycles.